Latest Insider Transactions at Zai Lab LTD (ZLAB)
This section provides a real-time view of insider transactions for Zai Lab LTD (ZLAB). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Zai Lab Ltd to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Zai Lab Ltd's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 03
2023
|
William Lis |
SELL
Open market or private sale
|
Direct |
5,434
-18.89%
|
$206,492
$38.31 P/Share
|
|
Mar 03
2023
|
Du Ying Chairperson & CEO |
SELL
Bona fide gift
|
Direct |
43,128
-2.54%
|
-
|
|
Dec 30
2022
|
Harald Reinhart |
SELL
Payment of exercise price or tax liability
|
Direct |
5,903
-23.74%
|
$177,090
$30.7 P/Share
|
|
Dec 30
2022
|
Rafael Amado |
BUY
Grant, award, or other acquisition
|
Direct |
126,000
+50.0%
|
-
|
|
Dec 08
2022
|
Peter Wirth |
SELL
Open market or private sale
|
Indirect |
4,000
-100.0%
|
$140,000
$35.33 P/Share
|
|
Dec 08
2022
|
Peter Wirth |
SELL
Open market or private sale
|
Direct |
3,852
-1.11%
|
$134,820
$35.37 P/Share
|
|
Nov 15
2022
|
Harald Reinhart |
SELL
Open market or private sale
|
Direct |
1,854
-3.48%
|
$74,160
$40.01 P/Share
|
|
Nov 15
2022
|
Harald Reinhart |
BUY
Exercise of conversion of derivative security
|
Direct |
1,854
+6.49%
|
$5,562
$3.0 P/Share
|
|
Aug 17
2022
|
Frazor Titus Edmondson Iii Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,181
-12.91%
|
$50,783
$43.52 P/Share
|
|
Aug 17
2022
|
Frazor Titus Edmondson Iii Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,850
+34.65%
|
$208,550
$43.52 P/Share
|
|
Jun 21
2022
|
Du Ying Chairperson & CEO |
SELL
Bona fide gift
|
Direct |
120,000
-12.26%
|
-
|
|
Apr 01
2022
|
Du Ying Chairperson & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
828
-0.08%
|
$37,260
$45.47 P/Share
|
|
Apr 01
2022
|
Harald Reinhart |
SELL
Payment of exercise price or tax liability
|
Direct |
246
-0.98%
|
$11,070
$45.47 P/Share
|
|
Apr 01
2022
|
Alan B. Sandler Head of Global Dev., Oncology |
BUY
Exercise of conversion of derivative security
|
Direct |
1,060
+3.53%
|
-
|
|
Apr 01
2022
|
Yi Liang CCO & President, Greater China |
BUY
Exercise of conversion of derivative security
|
Direct |
730
+0.69%
|
-
|
|
Apr 01
2022
|
Du Ying Chairperson & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,400
+0.33%
|
-
|
|
Apr 01
2022
|
Harald Reinhart |
BUY
Exercise of conversion of derivative security
|
Direct |
1,010
+3.87%
|
-
|
|
Apr 01
2022
|
Frazor Titus Edmondson Iii Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
830
+3.36%
|
-
|
|
Apr 01
2022
|
William Ki Chul Cho Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
920
+1.77%
|
-
|
|
Feb 04
2022
|
John D Diekman |
SELL
Open market or private sale
|
Direct |
1,000
-1.46%
|
$50,000
$50.17 P/Share
|
|
Jan 28
2022
|
Du Ying Chairperson & CEO |
SELL
Bona fide gift
|
Direct |
9,000
-0.91%
|
-
|
|
Jan 20
2022
|
William Lis |
SELL
Open market or private sale
|
Direct |
1,926
-5.34%
|
$102,078
$53.4 P/Share
|
|
Jan 05
2022
|
Du Ying Chairperson & CEO |
SELL
Bona fide gift
|
Direct |
15,250
-0.51%
|
-
|
|
Jan 05
2022
|
Du Ying Chairperson & CEO |
BUY
Bona fide gift
|
Indirect |
475
+50.0%
|
-
|
|
Jan 03
2022
|
John D Diekman |
BUY
Grant, award, or other acquisition
|
Direct |
7,763
+10.16%
|
-
|
|
Jan 03
2022
|
Kai Xian Chen |
BUY
Grant, award, or other acquisition
|
Direct |
7,763
+19.32%
|
-
|
|
Jan 03
2022
|
William Lis |
BUY
Grant, award, or other acquisition
|
Direct |
7,763
+17.72%
|
-
|
|
Jan 03
2022
|
Leon O Moulder Jr |
BUY
Grant, award, or other acquisition
|
Direct |
7,763
+26.42%
|
-
|
|
Jan 03
2022
|
Peter Wirth |
BUY
Grant, award, or other acquisition
|
Direct |
7,763
+2.17%
|
-
|
|
Dec 29
2021
|
Harald Reinhart |
SELL
Payment of exercise price or tax liability
|
Direct |
5,903
-19.68%
|
$407,307
$69.23 P/Share
|
|
Dec 21
2021
|
Harald Reinhart |
BUY
Grant, award, or other acquisition
|
Direct |
30,000
+50.0%
|
-
|
|
Dec 08
2021
|
Peter Wirth |
BUY
Open market or private purchase
|
Direct |
4,000
+1.15%
|
$284,000
$71.36 P/Share
|
|
Dec 01
2021
|
Alan B. Sandler Head of Global Dev., Oncology |
SELL
Payment of exercise price or tax liability
|
Direct |
2,075
-6.92%
|
$147,325
$71.23 P/Share
|
|
Nov 19
2021
|
Richard Gaynor |
BUY
Grant, award, or other acquisition
|
Direct |
8,912
+50.0%
|
-
|
|
Nov 05
2021
|
John D Diekman |
SELL
Open market or private sale
|
Direct |
1,000
-1.62%
|
$91,000
$91.65 P/Share
|
|
Oct 28
2021
|
Tao Fu President & COO |
SELL
Open market or private sale
|
Indirect |
10,000
-5.82%
|
$1,040,000
$104.81 P/Share
|
|
Oct 18
2021
|
Scott W Morrison |
BUY
Grant, award, or other acquisition
|
Direct |
7,345
+50.0%
|
-
|
|
Oct 14
2021
|
Tao Fu President & COO |
SELL
Open market or private sale
|
Indirect |
10,000
-3.53%
|
$1,020,000
$102.79 P/Share
|
|
Sep 30
2021
|
Tao Fu President & COO |
SELL
Open market or private sale
|
Indirect |
10,000
-2.4%
|
$1,070,000
$107.25 P/Share
|
|
Sep 24
2021
|
Tao Fu President & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
19,832
-9.56%
|
$2,360,008
$119.86 P/Share
|
|
Sep 20
2021
|
Nisa Leung Director |
BUY
Other acquisition or disposition
|
Direct |
63,095
+50.0%
|
-
|
|
Sep 20
2021
|
Nisa Leung Director |
SELL
Other acquisition or disposition
|
Indirect |
1,150,000
-12.68%
|
-
|
|
Sep 15
2021
|
Tao Fu President & COO |
SELL
Open market or private sale
|
Direct |
10,000
-0.59%
|
$1,290,000
$129.83 P/Share
|
|
Sep 15
2021
|
Tao Fu President & COO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+4.4%
|
$180,000
$18.92 P/Share
|
|
Sep 09
2021
|
Harald Reinhart |
SELL
Open market or private sale
|
Direct |
10,000
-35.22%
|
$1,420,000
$142.02 P/Share
|
|
Sep 09
2021
|
Harald Reinhart |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+50.0%
|
$30,000
$3.0 P/Share
|
|
Sep 07
2021
|
Du Ying Chairperson & CEO |
SELL
Open market or private sale
|
Direct |
29,785
-0.36%
|
$4,437,965
$149.07 P/Share
|
|
Sep 07
2021
|
Harald Reinhart |
SELL
Open market or private sale
|
Direct |
10,000
-36.1%
|
$1,480,000
$148.75 P/Share
|
|
Sep 07
2021
|
Harald Reinhart |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+50.0%
|
$30,000
$3.0 P/Share
|
|
Sep 03
2021
|
Du Ying Chairperson & CEO |
SELL
Open market or private sale
|
Direct |
24,145
-0.57%
|
$3,501,025
$145.26 P/Share
|